In vitro characterization of a novel series of platelet-derived growth factor receptor tyrosine kinase inhibitors
- 28 June 1996
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 51 (12) , 1631-1638
- https://doi.org/10.1016/0006-2952(96)00112-8
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- 5,7-Dimethoxy-3-(4-Pyridinyl)Quinoline Is a Potent and Selective Inhibitor of Human Vascular .beta.-Type Platelet-Derived Growth Factor Receptor Tyrosine KinaseJournal of Medicinal Chemistry, 1994
- Signal transduction by the PDGF receptorsProgress in Growth Factor Research, 1994
- Tyrphostins inhibit PDGF-induced DNA synthesis and associated early events in smooth muscle cellsAmerican Journal of Physiology-Cell Physiology, 1991
- Assessment of Fura-2 for measurements of cytosolic free calciumCell Calcium, 1990
- Direct activation of the serine/threonine kinase activity of raf-1 through tyrosine phosphorylation by the PDGF β-receptorCell, 1989
- PLATELET-DERIVED GROWTH FACTORThe Lancet, 1989
- Role of Phosphatidylinositol Kinase in PDGF Receptor Signal TransductionScience, 1989
- Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptorsNature, 1986
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986
- Pyrimidones. 2. Synthesis and reactions of 2‐chloropyrimidinesJournal of Heterocyclic Chemistry, 1980